A First-in-Human Safety Trial of MTX-463

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
A randomized, double-blind, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study to assess the safety, tolerability, and PK of single and multiple ascending doses of MTX-463 administered in healthy adults.
Epistemonikos ID: ad7bcf30c3d54734211f6da10ba198343a87782a
First added on: May 22, 2024